Cargando…

P987: IRAK1 AND JAK2 DUAL INHIBITION WITH PACRITINIB PREVENTS MYELOFIBROSIS-LIKE PHENOTYPE IN AN INFLAMMATION-DRIVEN MURINE MODEL

Detalles Bibliográficos
Autores principales: Zamora, Ernesto José Cuenca, Carrillo, Pedro Jesús Guijarro, Poveda, María José López, Fernández, María Luz Morales, Lozano, Maria L, González-Conejero, Rocío, Martínez, Constantino, Teruel Montoya, Raúl, Ferrer-Marín, Francisca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431327/
http://dx.doi.org/10.1097/01.HS9.0000970852.08349.b7
_version_ 1785091174679183360
author Zamora, Ernesto José Cuenca
Carrillo, Pedro Jesús Guijarro
Poveda, María José López
Fernández, María Luz Morales
Lozano, Maria L
González-Conejero, Rocío
Martínez, Constantino
Teruel Montoya, Raúl
Ferrer-Marín, Francisca
author_facet Zamora, Ernesto José Cuenca
Carrillo, Pedro Jesús Guijarro
Poveda, María José López
Fernández, María Luz Morales
Lozano, Maria L
González-Conejero, Rocío
Martínez, Constantino
Teruel Montoya, Raúl
Ferrer-Marín, Francisca
author_sort Zamora, Ernesto José Cuenca
collection PubMed
description
format Online
Article
Text
id pubmed-10431327
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104313272023-08-17 P987: IRAK1 AND JAK2 DUAL INHIBITION WITH PACRITINIB PREVENTS MYELOFIBROSIS-LIKE PHENOTYPE IN AN INFLAMMATION-DRIVEN MURINE MODEL Zamora, Ernesto José Cuenca Carrillo, Pedro Jesús Guijarro Poveda, María José López Fernández, María Luz Morales Lozano, Maria L González-Conejero, Rocío Martínez, Constantino Teruel Montoya, Raúl Ferrer-Marín, Francisca Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431327/ http://dx.doi.org/10.1097/01.HS9.0000970852.08349.b7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Zamora, Ernesto José Cuenca
Carrillo, Pedro Jesús Guijarro
Poveda, María José López
Fernández, María Luz Morales
Lozano, Maria L
González-Conejero, Rocío
Martínez, Constantino
Teruel Montoya, Raúl
Ferrer-Marín, Francisca
P987: IRAK1 AND JAK2 DUAL INHIBITION WITH PACRITINIB PREVENTS MYELOFIBROSIS-LIKE PHENOTYPE IN AN INFLAMMATION-DRIVEN MURINE MODEL
title P987: IRAK1 AND JAK2 DUAL INHIBITION WITH PACRITINIB PREVENTS MYELOFIBROSIS-LIKE PHENOTYPE IN AN INFLAMMATION-DRIVEN MURINE MODEL
title_full P987: IRAK1 AND JAK2 DUAL INHIBITION WITH PACRITINIB PREVENTS MYELOFIBROSIS-LIKE PHENOTYPE IN AN INFLAMMATION-DRIVEN MURINE MODEL
title_fullStr P987: IRAK1 AND JAK2 DUAL INHIBITION WITH PACRITINIB PREVENTS MYELOFIBROSIS-LIKE PHENOTYPE IN AN INFLAMMATION-DRIVEN MURINE MODEL
title_full_unstemmed P987: IRAK1 AND JAK2 DUAL INHIBITION WITH PACRITINIB PREVENTS MYELOFIBROSIS-LIKE PHENOTYPE IN AN INFLAMMATION-DRIVEN MURINE MODEL
title_short P987: IRAK1 AND JAK2 DUAL INHIBITION WITH PACRITINIB PREVENTS MYELOFIBROSIS-LIKE PHENOTYPE IN AN INFLAMMATION-DRIVEN MURINE MODEL
title_sort p987: irak1 and jak2 dual inhibition with pacritinib prevents myelofibrosis-like phenotype in an inflammation-driven murine model
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431327/
http://dx.doi.org/10.1097/01.HS9.0000970852.08349.b7
work_keys_str_mv AT zamoraernestojosecuenca p987irak1andjak2dualinhibitionwithpacritinibpreventsmyelofibrosislikephenotypeinaninflammationdrivenmurinemodel
AT carrillopedrojesusguijarro p987irak1andjak2dualinhibitionwithpacritinibpreventsmyelofibrosislikephenotypeinaninflammationdrivenmurinemodel
AT povedamariajoselopez p987irak1andjak2dualinhibitionwithpacritinibpreventsmyelofibrosislikephenotypeinaninflammationdrivenmurinemodel
AT fernandezmarialuzmorales p987irak1andjak2dualinhibitionwithpacritinibpreventsmyelofibrosislikephenotypeinaninflammationdrivenmurinemodel
AT lozanomarial p987irak1andjak2dualinhibitionwithpacritinibpreventsmyelofibrosislikephenotypeinaninflammationdrivenmurinemodel
AT gonzalezconejerorocio p987irak1andjak2dualinhibitionwithpacritinibpreventsmyelofibrosislikephenotypeinaninflammationdrivenmurinemodel
AT martinezconstantino p987irak1andjak2dualinhibitionwithpacritinibpreventsmyelofibrosislikephenotypeinaninflammationdrivenmurinemodel
AT teruelmontoyaraul p987irak1andjak2dualinhibitionwithpacritinibpreventsmyelofibrosislikephenotypeinaninflammationdrivenmurinemodel
AT ferrermarinfrancisca p987irak1andjak2dualinhibitionwithpacritinibpreventsmyelofibrosislikephenotypeinaninflammationdrivenmurinemodel